LIDDS AB (publ) announced that the following changes to its organisation have been implemented. Previous part-time Chief Medical Officer, Dr. Johan Harmenberg, has been replaced by Dr. Roger Belusa on a consultancy basis. Also, Annette Møldrup who was on a probation employment contract as CBDO has left the company, and the Business Development function is instead managed directly by CEO Anders Månsson and extended through the company's collaboration with Alira Health as previously announced.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1545 SEK | 0.00% | -4.04% | +43.06% |
May. 14 | LIDDS AB Announces CFO Changes, Effective 1 September 2024 | CI |
May. 14 | LIDDS AB Announces CEO Changes, Effective 1 September 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+43.06% | 1.97M | |
+7.65% | 115B | |
+12.72% | 107B | |
-13.44% | 22.31B | |
-3.99% | 21.6B | |
-6.59% | 18.23B | |
-39.93% | 17.62B | |
+6.76% | 14.26B | |
+32.90% | 12.37B | |
-27.78% | 8.28B |
- Stock Market
- Equities
- LIDDS Stock
- News LIDDS AB
- LIDDS AB Announces Management Changes